Mylan N.V. has announced that Mylan CEO Heather Bresch has been elected to serve as chair of the Generic Pharmaceutical Association’s (GPhA) board of directors.
GPhA is an association that represents the world’s leading generic drug manufacturers and suppliers and plays a critical role in tackling key issues affecting the generics industry and shaping policies that help ensure patients have access to high quality, affordable medicines.
Heather said, ‘In the decade since serving my last term as chair of GPhA, the generics industry has evolved significantly within an increasingly globalised market. Never has there been a greater need for our association to lead the way in shaping policy that expands access to high quality generic medicines and biosimilars, which is why I’ve committed to return to the role of chair and work with our industry’s leaders to influence positive change to our healthcare system.
‘In today’s political climate, no matter how strong each of us may be at an individual company level, it’s important for us to stand strongly together with a unified voice for the good of our shared mission of advancing access to more affordable medicine.’
Heather’s term as chair of GPhA will last for one year. Previously, she served two one-year terms as the chair of the association in 2004 and 2005 and two one-year terms as vice chair in 2003 and 2006.
